research
< (From left) Professor Gyu Rie Lee, Professor David Baker >
Under the foundation of research cooperation established through the Ministry of Science and ICT's InnoCORE (InnoCORE) project, KAIST InnoCORE researchers have derived meaningful research results. Following a visit by Professor David Baker (University of Washington, USA), the 2024 Nobel Laureate in Chemistry, KAIST has revealed research findings on designing proteins that accurately recognize desired compounds using AI through joint research.
KAIST announced on April 9th that Professor Gyu Rie Lee of the Department of Biological Sciences—a researcher participating in the AI-CRED Innovative Drug InnoCORE Research Group—successfully designed artificial proteins that selectively recognize specific compounds using AI through joint research with Professor David Baker.
This research is characterized by using AI to design proteins that recognize specific compounds from scratch (de novo) and implementing them as functional biosensors. While the conventional approach mainly involved searching natural proteins or modifying some of their functions, this research is highly significant in that it ‘custom-built’ proteins with desired functions through AI-based design and even completed experimental verification.
In particular, the research team successfully designed a protein that selectively recognizes the stress hormone cortisol and implemented an AI-designed biosensor based on it. This is evaluated as a case that extends beyond protein design to actual measurable sensor technology, solving the long-standing challenge of small-molecule recognition in the field of protein design.
These research results are expected to be utilized in various fields such as disease diagnosis, new drug development, and environmental monitoring in the future. It can precisely detect biomarkers in the blood to diagnose diseases early and contribute to the development of targeted therapies through the design of proteins that selectively recognize specific molecules. Furthermore, it is expected that the implementation of customized biosensor technology will become possible, such as real-time monitoring of air and water quality through the development of sensors that detect environmental pollutants.
Designing new proteins (de novo proteins) that recognize compounds has been considered a challenge in the field of protein design for a long time because it requires precise calculations at the atomic level. The research team developed an AI model that precisely reflects protein-ligand interactions and successfully designed binding proteins using it.
As a result, artificial binding proteins were designed for six types of compounds, including metabolites and small-molecule drugs, and their functions were verified through experiments. In particular, a cortisol biosensor was developed by designing a chemical-induced dimer based on a new protein that binds with cortisol. A provisional patent for the relevant design technology has been filed in the United States.
Professor Gyu Rie Lee stated, “This research experimentally proves that AI can be used to design proteins that precisely recognize specific compounds,” and added, “We plan to expand this into protein design technology that can be utilized in various fields such as disease diagnosis, new drug development, and environmental monitoring in the future.”
Professor Gyu Rie Lee of the KAIST Department of Biological Sciences participated in this research as the first author, and Professor David Baker as the corresponding author. The study was published in the international academic journal Nature Communications on March 28, 2026. ※ Paper Title: Small-molecule binding and sensing with a designed protein family DOI:
< Image of Research Content Summary >
Professor Gyu Rie Lee is a new professor who joined KAIST in February 2025 and leads the Protein Design Laboratory. She possesses world-class expertise in the field of precise protein complex design at the atomic level and is performing various research projects such as AI-based protein design, artificial enzyme design, and RNA-recognizing protein development. She is also participating as a mentor professor in the AI-CRED Innovative Drug Research Group of the InnoCORE project, conducting research on enzyme and peptide drug design.
Professor Lee conducted research as a postdoctoral researcher and Staff Scientist in Professor David Baker’s laboratory (University of Washington, USA, Howard Hughes Medical Institute) from 2018 to 2024. Professor David Baker is a world-renowned scholar in the field of protein structure prediction and design and was awarded the Nobel Prize in Chemistry in 2024.
Director Do-Heon Lee, a mentor professor of the AI-CRED Innovative Drug Research Group, stated, “This achievement is a meaningful result derived through cooperation between InnoCORE researchers and a global scholar,” and added, “We will further strengthen our research capabilities based on active research collaboration with postdoctoral researchers recruited through the InnoCORE project to continue creating innovative results in the AI drug development and bio-fields.”
Meanwhile, KAIST will host a lecture on Thursday, April 9th at 4 PM in the KI Building Fusion Hall featuring Professor David Baker and Professor Hannele Ruohola-Baker (University of Washington, USA) under the theme of ‘Advances in AI-powered protein design and biomedical science’ to mark Professor David Baker’s visit to Korea. This event is held with the support of the KAIST International Scholar Invitation Program, KAI-X, the InnoCORE AI-CRED Innovative Drug Group, and the Ministry of Science and ICT’s Overseas Excellent Research Institute Cooperation Hub Construction Project.
< Poster for Professor David Baker’s Invited Lecture >
KAIST President Kwang Hyung Lee stated, “Through cooperation with Nobel Laureate Professor David Baker, we have derived a meaningful achievement in AI-based protein design,” and added, “This research is an example showing that KAIST is leading innovative research alongside world-class research institutions.”
Meanwhile, the KAIST InnoCORE Research Group aims to accelerate AI-based scientific and technological innovation and promote global joint research by supporting top-tier domestic and international postdoctoral researchers to devote themselves to the development of AI convergence technology in a cutting-edge collective research environment. As the lead institution, KAIST operates the ▲Hyper-scale Large Language Model Innovation Research Group ▲AI-based Intelligent Design-Manufacturing Integration Research Group ▲AI-CRED Innovative Drug Research Group and ▲AI-Transformed Aerospace Research Group.
-
research KAIST Researchers Uncover How Neurons Deliver RNA to Where It Is Needed
Much like a courier reading an address on a package, neurons must deliver RNA to the precise locations where it is needed. A KAIST research team has discovered how a small chemical modification on RNA acts as a “delivery tag,” helping selected RNAs travel to distant regions of neurons. The findings provide a basis for investigating RNA “delivery errors” in brain disorders—cases in which RNA is produced normally but fails to reach its intended destination—an
2026-09-14 -
research KAIST and KIOM Develop a Wearable Microneedle Electroceutical for Personalized Pain Management
A "wearable electroceutical" has been developed that could reduce the need to visit a hospital or rely on painkillers every time pain occurs. When attached to the skin, it modulates pain through electrical stimulation and can be remotely controlled via smartphone even across long distances, such as between Korea and the United States. KAIST (President Choongsik Bae) announced on September 13 that a joint research team led by Professor Jae-Woong Jeong from the School of Electrical Engineering
2026-09-14 -
research KAIST Develops AI That Can Sense “That’s Not What I Meant” Without Being Told
A future in which AI can recognize a person’s unspoken “that’s not what I meant” response from brain signals and adjust its behavior on its own is coming closer. KAIST researchers have developed a technology that detects cognitive mismatch between humans and AI through brainwaves, enabling AI systems to revise their actions in real time according to human goals. The achievement is expected to accelerate the shift from AI that follows explicit commands to AI that can inf
2026-09-10 -
research Vitamin A Derivative Preserves T Cells’ Function as KAIST Points to a New Strategy for Treating Intractable Brain Tumors
Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells. This phenomenon is particularly pronounced in aggressive brain tumors and can severely limit the effectiveness of immunotherapy. A KAIST research team has now discovered that all-trans retinoic acid (ATRA), a vitamin A derivative, may help prevent such exhaustion and enhance the efficacy of immune checkpoint inhibitors. KAIST (President Choongsik Bae) announced on Septem
2026-09-08 -
research KAIST Develops Smartphone-Based Technology to Detect Hidden Cameras
A smartphone can now be transformed into a “hidden-camera detector.” KAIST researchers have developed an AI technology that can detect hidden cameras using only a smartphone and a low-cost LED device. This new security technology enables users to protect their privacy more easily and is expected to help prevent illegal filming in everyday spaces such as hotels and short-term rentals. KAIST (President Choongsik Bae) announced on August 30 that a research team led by Professor Jun
2026-08-31